日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer

蛋白偶联的吻肽受体诱导雌激素受体阴性乳腺癌的代谢重编程和肿瘤发生

Magdalena Dragan, Mai-Uyen Nguyen, Stephania Guzman, Cameron Goertzen, Muriel Brackstone, Waljit S Dhillo, Paul R Bech, Sophie Clarke, Ali Abbara, Alan B Tuck, David A Hess, Sharon R Pine, Wei-Xing Zong, Frederic E Wondisford, Xiaoyang Su, Andy V Babwah, Moshmi Bhattacharya

Isoform-specific promotion of breast cancer tumorigenicity by TBX3 involves induction of angiogenesis

TBX3 异构体特异性促进乳腺癌致瘤性涉及诱导血管生成

Milica Krstic, Haider M Hassan, Bart Kolendowski, M Nicole Hague, Pieter H Anborgh, Carl O Postenka, Joseph Torchia, Ann F Chambers, Alan B Tuck

Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis

侵袭性足是一种化学感应突起,可引导癌细胞外渗,促进转移至脑部

Karla C Williams, Mario A Cepeda, Sumreen Javed, Karlee Searle, Katie M Parkins, Ashley V Makela, Amanda M Hamilton, Sepideh Soukhtehzari, Yohan Kim, Alan B Tuck, John A Ronald, Paula J Foster, Ann F Chambers, Hon S Leong

TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG

TBX3 通过诱导 EMT 和直接上调 SLUG 来促进乳腺癌细胞的进展

Milica Krstic, Bart Kolendowski, Matthew J Cecchini, Carl O Postenka, Haider M Hassan, Joseph Andrews, Connor D MacMillan, Karla C Williams, Hon S Leong, Muriel Brackstone, Joseph Torchia, Ann F Chambers, Alan B Tuck

Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer

骨桥蛋白作为三阴性乳腺癌抗 EGFR 治疗的预测生物标志物的作用

Pieter H Anborgh, Danny J Lee, Pieter F Stam, Alan B Tuck, Ann F Chambers

Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization

全基因组分析揭示了 TDG 在雌激素受体介导的增强子 RNA 转录和三维重组中的作用

Bart Kolendowski, Haider Hassan, Milica Krstic, Majdina Isovic, Gobi Thillainadesan, Ann F Chambers, Alan B Tuck, Joseph Torchia

The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer

转录调控因子 TBX3 促进乳腺癌从非侵袭性进展为侵袭性

Milica Krstic, Connor D Macmillan, Hon S Leong, Allen G Clifford, Lesley H Souter, David W Dales, Carl O Postenka, Ann F Chambers, Alan B Tuck

Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial

早期乳腺癌中骨桥蛋白的评估:随机临床试验中的相关性研究

Vivien H C Bramwell, Alan B Tuck, Judith-Anne W Chapman, Pieter H Anborgh, Carl O Postenka, Waleed Al-Katib, Lois E Shepherd, Lei Han, Carolyn F Wilson, Kathleen I Pritchard, Michael N Pollak, Ann F Chambers

Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway

乳腺癌进展阶段影响细胞对 WNT/平面细胞极性通路激活的反应

Connor D MacMillan, Hon S Leong, David W Dales, Amy E Robertson, John D Lewis, Ann F Chambers, Alan B Tuck

Osteopontin increases breast cancer cell sensitivity to specific signaling pathway inhibitors in preclinical models

骨桥蛋白在临床前模型中增加乳腺癌细胞对特定信号通路抑制剂的敏感性

Jennifer C Mutrie, Ann F Chambers, Alan B Tuck